Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for ...
With PFITRE, Brookhaven scientists achieve breakthrough 3D imaging in nanoscale X-ray tomography, combining AI and physics ...
Optical Coherence Tomography (OCT) Market Report 2025" has been added to ResearchAndMarkets.com's offering. The artificial ...
Tech Xplore on MSN
Novel AI method sharpens 3D X-ray vision
X-ray tomography is a powerful tool that enables scientists and engineers to peer inside of objects in 3D, including computer ...
Brookhaven researchers combine AI and physics to improve 3D X-ray tomography for nanoscale imaging. Read more.
"We are committed to leveraging advanced imaging to address critical healthcare challenges worldwide," said David Specht, CEO and co-founder of MAUI Imaging. "We believe our CET solution can transform ...
Bayer to acquire AT-01 & AT-05, investigational molecular imaging agents for the diagnosis of cardiac amyloidosis from Attralus: Berlin, Germany Wednesday, January 14, 2026, 11:00 ...
Lumexa Imaging (LMRI) rated Buy: resilient outpatient imaging demand, hospital JV moat, and scale-driven FCF growth.
NOVI, Mich.--(BUSINESS WIRE)--Delphinus Medical Technologies, a pioneering medical imaging company that developed the SoftVue™ Breast Ultrasound Tomography (UST), today announced the latest ...
A new hand-held scanner can generate highly detailed 3D photoacoustic images in just seconds, paving the way for their use in a clinical setting for the first time and offering the potential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback